ENG and metastatic malignant neoplasm in the lymph nodes: According to DCA, in our study, the addition of endoglin improved the clinical net benefit of the standard model for the prediction of lymph node metastasis; indeed, 67.8% of patients would benefit from the novel model featuring endoglin.